Health Matters

02/23/2026

Getting lean isnt so hard-when you know the science method

The Science Behind Fat Burning

02/22/2026

edging closer to a cure

Researchers at Karolinska Institutet have identified two specific receptor proteins in the brain that, when activated, boost the organ’s built-in ability to break down the amyloid-beta plaques associated with Alzheimer’s disease. The discovery centers on somatostatin receptor subtypes SST1 and S...

02/21/2026

Another anti cancer therapy

Revolutionary cancer therapy awakens the body’s own natural defences

Dr. Patrick Soon-Shiong unveiled his latest breakthrough: the Anktiva cancer treatment, designed to activate the body’s natural cancer-killing cells. Unlike conventional therapies such as chemotherapy or radiation, which attack cancer indiscriminately, Anktiva works by empowering the immune system to recognise and destroy cancer cells on its own.

This innovative approach represents a paradigm shift in oncology. By harnessing the body’s innate defence mechanisms, patients could potentially experience fewer side effects while achieving more targeted and effective treatment. Early studies suggest promising results in multiple types of cancer, highlighting the potential of immunotherapy to transform lives.

Dr. Soon-Shiong’s work builds on decades of research into immune system activation and personalised medicine. By combining cutting-edge biotechnology with a deep understanding of cellular biology, Anktiva may pave the way for therapies that are not only more effective but also more humane, sparing patients the harsh toll of traditional treatments.

Imagine a future where the body itself becomes the most powerful weapon against cancer, with treatments that are personalised, precise, and life-saving. Innovations like Anktiva remind us that the frontier of medicine is limitless, and that the tiniest cells in our body may hold the key to conquering one of humanity’s greatest challenges.

\

02/21/2026

knowing is better than not

A revolutionary finger-prick test developed in Sweden could replace invasive spinal taps for Alzheimer's patients.

02/21/2026

Wow this is crazy!!

What if the very cells designed to protect you are secretly helping cancer grow? Scientists from the University of Geneva and the Ludwig Institute for Cancer Research have uncovered a shocking discovery. Neutrophils, one of the immune system’s most powerful defenders, can be reprogrammed by tumors...

02/19/2026

Interesting

Some brain cells can resist the toxic processes associated with Alzheimer's disease and other forms of dementia. Scientists have now identified the "cellular hazmat team" that keeps neurons healthy. Neurodegenerative diseases like dementia are characterized by proteins that aggregate in the brain an...

02/17/2026

Vaccinations are very important, despite what JFK Jnr says

In addition to cancer, a growing body of research has shown that vaccines can reduce the risk of developing dementia and heart conditions.

02/17/2026

wow

Laboratory research has reported that peppermint essential oil showed strong cytotoxic effects against a specific human throat cancer cell line known as HN0210 under controlled conditions. In vitro testing indicated that concentrations above two hundred micrograms per milliliter significantly reduced cancer cell viability within twenty four hours.

Scientists observed that at higher exposure levels, many of the cancer cells were eliminated. The proposed mechanism involves disruption of cellular membranes, oxidative stress induction, and activation of apoptosis, a programmed cell death pathway. Essential oils contain bioactive compounds such as menthol and menthone that may contribute to these effects.

However, it is important to clarify that these findings come from laboratory cell culture studies, not from human clinical trials. Results observed in petri dishes do not automatically translate to safe or effective treatments in patients. Dosage, delivery method, toxicity, and systemic effects require rigorous evaluation before any therapeutic use can be considered.

Medical experts caution against self treatment with essential oils for cancer. While natural compounds continue to inspire pharmaceutical research, proper clinical validation is essential to determine safety and effectiveness in real world settings.

02/17/2026

Interesting research report

A cheap anti-seizure drug may help prevent the brain plaques linked to Alzheimer’s disease, new research suggests. Scientists found that levetiracetam blocks production of a toxic protein called amyloid-beta 42, stopping plaques before they form. The study indicates treatment would need to begin v...

02/12/2026

Fantastic research

🚨 Scientists have used CRISPR to remove the extra chromosome responsible for Down syndrome — restoring normal function in lab-grown cells.

In a major breakthrough in genetic research, scientists at Mie University in Japan have demonstrated that CRISPR-Cas9 can do something once thought impossible: selectively remove an entire extra chromosome from human cells.

Down syndrome is caused by trisomy 21, where cells carry three copies of chromosome 21 instead of two. In this new study, researchers successfully eliminated the extra chromosome in laboratory-grown human cells — a process known as “trisomic rescue.”

After the removal, the edited cells showed normalized gene activity, healthier growth patterns, and reduced cellular stress, indicating a return toward typical cellular function. Notably, the technique worked not only in stem cells but also in fully developed skin cells, suggesting the approach could be broadly applicable.

While this research is still far from clinical use and raises important ethical and safety considerations, it represents a huge leap forward in genome editing. Until now, CRISPR has primarily been used to modify small sections of DNA. This study shows that entire chromosomes can be precisely targeted, opening new possibilities for understanding and potentially treating conditions rooted in chromosomal abnormalities.

The findings highlight how increasing the precision of gene-editing tools could one day support advances in regenerative medicine and genetic disorder research.

📰 Source: PNAS Nexus

02/12/2026

🚨 Scientists have used CRISPR to remove the extra chromosome responsible for Down syndrome — restoring normal function in lab-grown cells.

In a major breakthrough in genetic research, scientists at Mie University in Japan have demonstrated that CRISPR-Cas9 can do something once thought impossible: selectively remove an entire extra chromosome from human cells.

Down syndrome is caused by trisomy 21, where cells carry three copies of chromosome 21 instead of two. In this new study, researchers successfully eliminated the extra chromosome in laboratory-grown human cells — a process known as “trisomic rescue.”

After the removal, the edited cells showed normalized gene activity, healthier growth patterns, and reduced cellular stress, indicating a return toward typical cellular function. Notably, the technique worked not only in stem cells but also in fully developed skin cells, suggesting the approach could be broadly applicable.

While this research is still far from clinical use and raises important ethical and safety considerations, it represents a huge leap forward in genome editing. Until now, CRISPR has primarily been used to modify small sections of DNA. This study shows that entire chromosomes can be precisely targeted, opening new possibilities for understanding and potentially treating conditions rooted in chromosomal abnormalities.

The findings highlight how increasing the precision of gene-editing tools could one day support advances in regenerative medicine and genetic disorder research.

📰 Source: PNAS Nexus

02/12/2026

Great article

Scientists may have found a permanent way to prevent Alzheimer’s disease

Leading pharmaceutical companies announced a revolutionary breakthrough: a four-hour “Gene-Vac” treatment that can permanently remove the genetic predisposition for Alzheimer’s disease. Unlike traditional approaches, which focus on slowing cognitive decline or managing symptoms, this innovative therapy targets the root cause at the DNA level. By precisely editing the genes linked to Alzheimer’s, the treatment eliminates the risk before symptoms ever appear.

This procedure works quickly and safely, reshaping how we think about hereditary diseases. In just four hours, patients could leave with a dramatically reduced likelihood of developing Alzheimer’s in their lifetime. Current methods, such as medications or lifestyle interventions, can only delay the onset or ease the effects of the disease. Gene-Vac represents a paradigm shift, moving from management to true prevention.

The implications are profound. Millions of families affected by Alzheimer’s could see a future free from the fear and heartbreak of this neurodegenerative disease. Healthcare systems could save billions currently spent on long-term care, while patients maintain cognitive health well into old age. Beyond Alzheimer’s, this technology opens the door to preventing other genetically linked diseases, giving humanity a new tool to reshape health at the molecular level.

This discovery invites hope and imagination. It challenges centuries of assumptions about ageing and heredity, suggesting that the future of medicine may not be reactive but proactive, and that life-altering conditions can be prevented before they start. As science continues to advance, the dream of a world where Alzheimer’s is no longer inevitable may soon become reality.